PISCES (2026) — Trial Summary

PISCES (2026): Double-blind, randomized, placebo-controlled trial at 26 sites in Canada and Australia assigning 1,228 adults on maintenance hemodialysis to daily fish oil (4 g n−3 polyunsaturated fatty acids: 1.6 g EPA + 0.8 g DHA) or corn-oil placebo (ISRCTN00691795). Primary end point: composite o

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.